Topical Pain Relief Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth And Forecast 2022-2027

Report Code: HCR 93908 Report Format: PDF + Excel

Topical Pain Relief Market Overview

Topical Pain Relief Market size is estimated to reach $12.1 billion by 2027, growing at a CAGR of 5.3% during the forecast period 2022-2027. The word “Topical” signifies administering something unswervingly to body parts. Therefore, topical medication includes several medicines in form of creams, sprays, and many more that are used as pain relievers. Innumerable Nonsteroidal anti-inflammatory drugs and cannabinoids are used to treat osteoarthritis, glaucoma, and chronic maladies such as heart attacks, blood clotting complications, tenderness, and Agony. Other than that, Tricyclic antidepressants like Amoxapine, Norpramin, and Amitriptyline have come to the forefront as depression has become an indispensable part of contemporary society.

Elevation in misfortunes like road crashes fatalities power the demand for anesthetics as such drugs anesthetize administered part of the body and succor doctors to execute medical procedures. Heightening the old age population across the globe is set to drive the growth of the Topical Pain Relief Industry for the period 2022-2027.

Report Coverage:

The report: “Topical Pain Relief Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Topical Pain Relief Market.

By Class: Opioids/Narcotics, and Non-Opioids.

By Medication type: Advised Drugs, Non-Prescribed/Over-The-Counter Drugs.

By Form: Sprays, Patches, Creams, and Foams.

By Distributional Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Platforms, and Others.

By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World (the Middle East and Africa).

Key Takeaways:

  • Geographically, the North America Topical Pain Relief Market accounted for the highest revenue share in 2021 owing to the presence of major pharma companies and the activities pertaining to R&D. However, Asia-pacific is poised to dominate the market over the period 2022-2027 owing to the surging prevalence of maladies such as osteoarthritis, glaucoma elevating the old-age population of Asian nations.
  • The increase in tragedies such as road accidents and other chronic ailments such as heart attack, blood clotting, etc. is driving the Topical Pain Relief market. However, side effects associated with several opioid and non-opioid drugs are one of the major factors that are said to reduce the growth of the Topical Pain Relief Market.
  • Detailed analysis on the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Topical Pain Relief Market report.

Topical Pain Relief Market- Geography (%) for 2021

Topical Pain Relief Market

For more details on this report - Request for Sample

Topical Pain Relief Market Segment Analysis-By Class

The Topical Pain Relief Market based on the class type can be further segmented into Opioids (Tapentadol, Oxycodone, Morphine, and others), non-opioids (Aleve, Tylenol, and others). The Opioid medications segment held the largest share in 2021 owing to the factors such as wide-ranging usage and accessibility of opioids. As the pervasiveness of numerous chronic sicknesses is shooting up so is the use of such narcotics. These drugs are fairly facilitative in discharging pains accompanied by a heart attack, back, joints, inflammation, etc.

Moreover, the Opioid segment is estimated to be the fastest-growing segment with a CAGR of 6.1% over the period 2022-2027. This growth is owing to the flourishing sporting culture around the globe leading to elevation in sports injuries, accruing elderly population, sweeping intensification in road accident incidents, broadening prevalence complications associated with joint disorders. Moreover, salts such as Tapentadol are recommended to be used for the treatment of neuropathic pain which is often seen in patients suffering from diabetes. The growing prevalence of diabetes, for example, in the US around 10.5% of the entire population is diabetic, and the prevalence is only growing owing to sedentary lifestyle and unhealthy eating habits.  The said reason can directly benefit the segment growth.

Topical Pain Relief Market Segment Analysis-By Distribution Channel

The Topical Pain Relief Market based on the Distribution channel can be further segmented into Hospital Pharmacies, Retail pharmacies, Drug stores, Online platforms, and Others. The Retail Pharmacy segment held the largest share in 2021 owing to the factors such as across the board presence of retail pharmacy stores even in pastoral areas. On another hand, maximum drugs in such stores are available without any prior prescription from a medical practitioner.

However, the online segment is estimated to be the fastest growing with a CAGR of 6.4% over the forecast period 2022-2027. This growth is owing to rapid digitalization resulting in better online infrastructure. Making online purchases instead of visiting drug stores extends a plethora of benefits such as convenience, saving time, universal presence of digital platforms as their delivery services are ubiquitous. In June 2021, Tata Digital Ltd acquired a majority stake of the online health platform- 1MG to now become Tata 1MG. Owing to such developments, the segment would offer steadfast opportunities.

Topical Pain Relief Market Segment Analysis-By Geography

The Topical Pain Relief based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held the largest share with 36% of the overall market in 2021. The growth in this segment is owing to the factors such as health acquainted population, superior healthcare infrastructures such as top-notch hospitals, high-class laboratories with world-class facilities in the US and Canada, an extensive network of retail pharmacies and drug stores in every state. Additionally, the geriatric population is on the verge to become extremely dominant. For example, as by 2060, adults above the age of 65+ would take up to 24%, which currently stands close to 16%.

However, Asia-pacific is estimated to be the fastest-growing segment over the forecast period 2022-2027. This growth is owing to augmenting the elderly population in several Asian nations especially in India and China, sweeping increase in chronic ailments and other joint disorders, expanding healthcare spending refining the medical sector.

Topical Pain Relief Market Drivers

  • Enlarging the old-age population across the globe is Projected to Drive Market Growth. 

Around 19% of total Europe’s population falls under the category of geriatric population. Similarly, 10.1% population in India belongs to the old-age category. Out of the total world’s population that is 7.9 billion a big faction of people is aging above 65 and is anticipated to widen up to 2 billion in the foreseeable future. As a result, are several complications such as muscle pain, osteoarthritis, heart attacks, etc. are preponderating and ultimately appraised to enhance the demand of the Topical Pain Relief market.

  • Expansion in osteoarthritic, chronic maladies, and sports or accident injuries are Expected to Boost Product Demand.

According to a report by the world health organization around 0.2 to 1% of 7.9 billion people are inflicted with rheumatoid arthritis an inflammatory sickness that leads to several complications from joint disorder to immune hitches. This percentage is anticipated to crest sweepingly in the upcoming future. In addition to that, as support culture is prevailing so are the sports injuries. According to the WHO report, approximately more than 1 million people deceased in road accidents and the majority of them happen in poor and developing countries. Therefore, the number is anticipated to go beyond 2-2.5 million as the purchasing power of people is shooting up and they are making automobile purchases.

Topical Pain Relief Market Challenges

  • A plethora of side effects associated with opioids is Anticipated to Hamper Market Growth.

Yes, Opioids are used astonishingly in treatments of joint complications, back pain, tenderness, headache, pain associated with cancer ailments, etc. but the dark side of these drugs is that these pose a plethora of hazardous side effects such as nausea, mild concussions, breathing complications, and many more. Besides these one of the prime hitches associated with these drugs is addiction. People become restless once they stop consuming such drugs which can be deadly.

Topical Pain Relief Market Competitive Landscape:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Topical Pain Relief Market.  The top 10 Topical Pain Relief market companies are

  1. Johnson & Johnson
  2. Sanofi
  3. Topical Biomedics Inc.
  4. Reckitt Benckiser Group Plc.
  5. Advacare pharma
  6. Pfizer
  7. Novartis AG
  8. Sun Pharmaceutical Industries Ltd.
  9. Nestle S.A.
  10. GlaxoSmithKline Plc.

Recent Developments

  • March 1, 2021, “Salonpas” a pain-relieving gel for patients inflicted with arthritis (knee, hands, ankles, etc.) is made available in the market. The topical gel is developed by Hisamitsu America. Hisamitsu America recently released the results of its latest clinical trial, bolstering the case for topical pain relievers as a first-line treatment for pain. Further, it is a non-greasy gel that helps in reducing inflammation and provides ease at the sight of pain.
  • In February 2020, US FDA upgraded and approved the status of three products. The said change is known as an Rx to OTC switch. Amongst the three products, Voltaren Arthritis Pain, an NSAID which works by reducing the substances which in turn cause pain in patients. The said drug was approved in 2007 but was under the jurisdiction of prescription medicine. Voltaren Arthritis Pain is not for immediate relief and may take up to 7 days to work.
  • In June 2020, GSK Consumer Healthcare has now teamed up with Paula Abdul, who would publicize the product “Voltaren Arthritis Pain Gel”, which has received the nod from FDA to be used as an OTC drug. The joint statement given confirms the message that “Staying active is important for arthritis patients everywhere, and together, Voltaren and Paula Abdul will inspire people to "rediscover the joy of movement". Moreover, the joint pain pertaining issues have been increasing owing to the lockdown like restrictions and work from home policies.

Relevant Links

Analgesics Market – Forecast (2022 - 2027)

Report Code: HCR 0116

Burn Ointment Market – Forecast (2022 - 2027)

Report Code: HCR 1394

For more Lifescience and Healthcare related reports, please click here

1. Topical Pain Relief Market Overview
    1.1 Definitions and Scope
2. Topical Pain Relief Market - Executive Summary
3. Topical Pain Relief Market – Market Landscape
    3.1 Company Benchmarking- Key Companies
    3.2 Key Company Financial Analysis
    3.3 Market Share Analysis
    3.4 Patent Analysis
    3.5 Pricing Analysis (Comparison of General Price Offerings in the Market)
4. Topical Pain Relief Market – Startup Company Scenario 
    4.1 Investment
    4.2 Revenue
    4.3 Venture Capital and Funding Scenario
5. Topical Pain Relief Market – Industry Market Entry Scenario Premium 
    5.1 Regulatory Scenario
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Topical Pain Relief Market - Market Forces
    6.1 Market Drivers
    6.2 Market Constraints
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Topical Pain Relief Market – By Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle Analysis
8. Topical Pain Relief Market - By Class (Market Size –$Million/$Billion) 
    8.1 Opioids/Narcotics (=Tapentadol, Oxycodone, Morphine, and others)
    8.2 Non-opioids (=Aleve, Tylenol, and others)
9. Topical Pain Relief Market – By Medication Type (Market Size –$Million/$Billion)
    9.1 Advised drugs
    9.2 Non-prescribed/Over-the-counter drugs
10. Topical Pain Relief Market – By Form (Market Size –$Million/$Billion) 
    10.1 Sprays
    10.2 Patches
    10.3 Creams
    10.4 Foams and Gels
11. Topical Pain Relief Market – By Distribution Channel (Market Size -$Million/Billion)
    11.1 Hospital Pharmacies
    11.2 Retail pharmacies
    11.3 Drug stores
    11.4 Online platforms
    11.5 Others
12. Topical Pain Relief Market – By Geography (Market Size -$Million/Billion)
    12.1 North America
        12.1.1 U.S
        12.1.2 Canada
        12.1.3 Mexico
    12.2 Europe
        12.2.1 Germany
        12.2.2 France
        12.2.3 UK
        12.2.4 Italy
        12.2.5 Spain
        12.2.6 Russia
        12.2.7 Rest of Europe
    12.3 Asia-Pacific
        12.3.1 China
        12.3.2 Japan
        12.3.3 South Korea
        12.3.4 India
        12.3.5 Australia & New Zealand
        12.3.6 Rest of APAC
    12.4 South America
        12.4.1 Brazil
        12.4.2 Argentina
        12.4.3 Chile
        12.4.4 Colombia
        12.4.5 Rest of South America
    12.5 Rest of World
        12.5.1 Middle East
        12.5.2 Africa
13. Topical Pain Relief Market - Market Entropy
    13.1 New product launches
    13.2 M&A's, collaborations, JVs, and partnerships
14. Topical Pain Relief Market – Industry Competition Landscape 
    14.1 Market Share Analysis
        14.1.1 Global Market Share – Key Companies
        14.1.2 Market Share by Region – Key Companies
        14.1.3 Market Share by Countries – Key Companies
    14.2 Competition Matrix
    14.3 Best Practices for Companies
15. Topical Pain Relief Market – Key Company List by Country Premium 
16. Topical Pain Relief Market - Company Analysis
    16.1 Company 1
    16.2 Company 2
    16.3 Company 3
    16.4 Company 4
    16.5 Company 5
    16.6 Company 6
    16.7 Company 7
    16.8 Company 8
    16.9 Company 9
    16.10 Company 10
"*Financials would be provided on a best-efforts basis for private companies"

LIST OF TABLES

1.Global Topical Pain Relief Market, By Therapeutic Class Market 2019-2024 ($M)
1.1 Non-Opioids Market 2019-2024 ($M) - Global Industry Research
1.1.1 Nonsteroidal Anti-Inflammatory Drug Market 2019-2024 ($M)
1.1.2 Methyl Salicylate Market 2019-2024 ($M)
1.1.3 Capsaicin Market 2019-2024 ($M)
1.1.4 Lidocaine Market 2019-2024 ($M)
1.2 Opioids Market 2019-2024 ($M) - Global Industry Research
1.2.1 Buprenorphine Market 2019-2024 ($M)
1.2.2 Fentanyl Market 2019-2024 ($M)
2.Global Topical Pain Relief Market, By Formulation Market 2019-2024 ($M)
2.1 Cream Market 2019-2024 ($M) - Global Industry Research
2.2 Gel Market 2019-2024 ($M) - Global Industry Research
2.3 Spray Market 2019-2024 ($M) - Global Industry Research
2.4 Patch Market 2019-2024 ($M) - Global Industry Research
3.Global Topical Pain Relief Market, By Type Market 2019-2024 ($M)
3.1 Prescription Pain Relief Market 2019-2024 ($M) - Global Industry Research
3.2 Over-The-Counter Pain Relief Market 2019-2024 ($M) - Global Industry Research
4.Global Topical Pain Relief Market, By Distribution Channel Market 2019-2024 ($M)
4.1 Pharmacy Drug Store Market 2019-2024 ($M) - Global Industry Research
4.2 E-Commerce Market 2019-2024 ($M) - Global Industry Research
4.3 Grocery Store Market 2019-2024 ($M) - Global Industry Research
5.Global Topical Pain Relief Market, By Therapeutic Class Market 2019-2024 (Volume/Units)
5.1 Non-Opioids Market 2019-2024 (Volume/Units) - Global Industry Research
5.1.1 Nonsteroidal Anti-Inflammatory Drug Market 2019-2024 (Volume/Units)
5.1.2 Methyl Salicylate Market 2019-2024 (Volume/Units)
5.1.3 Capsaicin Market 2019-2024 (Volume/Units)
5.1.4 Lidocaine Market 2019-2024 (Volume/Units)
5.2 Opioids Market 2019-2024 (Volume/Units) - Global Industry Research
5.2.1 Buprenorphine Market 2019-2024 (Volume/Units)
5.2.2 Fentanyl Market 2019-2024 (Volume/Units)
6.Global Topical Pain Relief Market, By Formulation Market 2019-2024 (Volume/Units)
6.1 Cream Market 2019-2024 (Volume/Units) - Global Industry Research
6.2 Gel Market 2019-2024 (Volume/Units) - Global Industry Research
6.3 Spray Market 2019-2024 (Volume/Units) - Global Industry Research
6.4 Patch Market 2019-2024 (Volume/Units) - Global Industry Research
7.Global Topical Pain Relief Market, By Type Market 2019-2024 (Volume/Units)
7.1 Prescription Pain Relief Market 2019-2024 (Volume/Units) - Global Industry Research
7.2 Over-The-Counter Pain Relief Market 2019-2024 (Volume/Units) - Global Industry Research
8.Global Topical Pain Relief Market, By Distribution Channel Market 2019-2024 (Volume/Units)
8.1 Pharmacy Drug Store Market 2019-2024 (Volume/Units) - Global Industry Research
8.2 E-Commerce Market 2019-2024 (Volume/Units) - Global Industry Research
8.3 Grocery Store Market 2019-2024 (Volume/Units) - Global Industry Research
9.North America Topical Pain Relief Market, By Therapeutic Class Market 2019-2024 ($M)
9.1 Non-Opioids Market 2019-2024 ($M) - Regional Industry Research
9.1.1 Nonsteroidal Anti-Inflammatory Drug Market 2019-2024 ($M)
9.1.2 Methyl Salicylate Market 2019-2024 ($M)
9.1.3 Capsaicin Market 2019-2024 ($M)
9.1.4 Lidocaine Market 2019-2024 ($M)
9.2 Opioids Market 2019-2024 ($M) - Regional Industry Research
9.2.1 Buprenorphine Market 2019-2024 ($M)
9.2.2 Fentanyl Market 2019-2024 ($M)
10.North America Topical Pain Relief Market, By Formulation Market 2019-2024 ($M)
10.1 Cream Market 2019-2024 ($M) - Regional Industry Research
10.2 Gel Market 2019-2024 ($M) - Regional Industry Research
10.3 Spray Market 2019-2024 ($M) - Regional Industry Research
10.4 Patch Market 2019-2024 ($M) - Regional Industry Research
11.North America Topical Pain Relief Market, By Type Market 2019-2024 ($M)
11.1 Prescription Pain Relief Market 2019-2024 ($M) - Regional Industry Research
11.2 Over-The-Counter Pain Relief Market 2019-2024 ($M) - Regional Industry Research
12.North America Topical Pain Relief Market, By Distribution Channel Market 2019-2024 ($M)
12.1 Pharmacy Drug Store Market 2019-2024 ($M) - Regional Industry Research
12.2 E-Commerce Market 2019-2024 ($M) - Regional Industry Research
12.3 Grocery Store Market 2019-2024 ($M) - Regional Industry Research
13.South America Topical Pain Relief Market, By Therapeutic Class Market 2019-2024 ($M)
13.1 Non-Opioids Market 2019-2024 ($M) - Regional Industry Research
13.1.1 Nonsteroidal Anti-Inflammatory Drug Market 2019-2024 ($M)
13.1.2 Methyl Salicylate Market 2019-2024 ($M)
13.1.3 Capsaicin Market 2019-2024 ($M)
13.1.4 Lidocaine Market 2019-2024 ($M)
13.2 Opioids Market 2019-2024 ($M) - Regional Industry Research
13.2.1 Buprenorphine Market 2019-2024 ($M)
13.2.2 Fentanyl Market 2019-2024 ($M)
14.South America Topical Pain Relief Market, By Formulation Market 2019-2024 ($M)
14.1 Cream Market 2019-2024 ($M) - Regional Industry Research
14.2 Gel Market 2019-2024 ($M) - Regional Industry Research
14.3 Spray Market 2019-2024 ($M) - Regional Industry Research
14.4 Patch Market 2019-2024 ($M) - Regional Industry Research
15.South America Topical Pain Relief Market, By Type Market 2019-2024 ($M)
15.1 Prescription Pain Relief Market 2019-2024 ($M) - Regional Industry Research
15.2 Over-The-Counter Pain Relief Market 2019-2024 ($M) - Regional Industry Research
16.South America Topical Pain Relief Market, By Distribution Channel Market 2019-2024 ($M)
16.1 Pharmacy Drug Store Market 2019-2024 ($M) - Regional Industry Research
16.2 E-Commerce Market 2019-2024 ($M) - Regional Industry Research
16.3 Grocery Store Market 2019-2024 ($M) - Regional Industry Research
17.Europe Topical Pain Relief Market, By Therapeutic Class Market 2019-2024 ($M)
17.1 Non-Opioids Market 2019-2024 ($M) - Regional Industry Research
17.1.1 Nonsteroidal Anti-Inflammatory Drug Market 2019-2024 ($M)
17.1.2 Methyl Salicylate Market 2019-2024 ($M)
17.1.3 Capsaicin Market 2019-2024 ($M)
17.1.4 Lidocaine Market 2019-2024 ($M)
17.2 Opioids Market 2019-2024 ($M) - Regional Industry Research
17.2.1 Buprenorphine Market 2019-2024 ($M)
17.2.2 Fentanyl Market 2019-2024 ($M)
18.Europe Topical Pain Relief Market, By Formulation Market 2019-2024 ($M)
18.1 Cream Market 2019-2024 ($M) - Regional Industry Research
18.2 Gel Market 2019-2024 ($M) - Regional Industry Research
18.3 Spray Market 2019-2024 ($M) - Regional Industry Research
18.4 Patch Market 2019-2024 ($M) - Regional Industry Research
19.Europe Topical Pain Relief Market, By Type Market 2019-2024 ($M)
19.1 Prescription Pain Relief Market 2019-2024 ($M) - Regional Industry Research
19.2 Over-The-Counter Pain Relief Market 2019-2024 ($M) - Regional Industry Research
20.Europe Topical Pain Relief Market, By Distribution Channel Market 2019-2024 ($M)
20.1 Pharmacy Drug Store Market 2019-2024 ($M) - Regional Industry Research
20.2 E-Commerce Market 2019-2024 ($M) - Regional Industry Research
20.3 Grocery Store Market 2019-2024 ($M) - Regional Industry Research
21.APAC Topical Pain Relief Market, By Therapeutic Class Market 2019-2024 ($M)
21.1 Non-Opioids Market 2019-2024 ($M) - Regional Industry Research
21.1.1 Nonsteroidal Anti-Inflammatory Drug Market 2019-2024 ($M)
21.1.2 Methyl Salicylate Market 2019-2024 ($M)
21.1.3 Capsaicin Market 2019-2024 ($M)
21.1.4 Lidocaine Market 2019-2024 ($M)
21.2 Opioids Market 2019-2024 ($M) - Regional Industry Research
21.2.1 Buprenorphine Market 2019-2024 ($M)
21.2.2 Fentanyl Market 2019-2024 ($M)
22.APAC Topical Pain Relief Market, By Formulation Market 2019-2024 ($M)
22.1 Cream Market 2019-2024 ($M) - Regional Industry Research
22.2 Gel Market 2019-2024 ($M) - Regional Industry Research
22.3 Spray Market 2019-2024 ($M) - Regional Industry Research
22.4 Patch Market 2019-2024 ($M) - Regional Industry Research
23.APAC Topical Pain Relief Market, By Type Market 2019-2024 ($M)
23.1 Prescription Pain Relief Market 2019-2024 ($M) - Regional Industry Research
23.2 Over-The-Counter Pain Relief Market 2019-2024 ($M) - Regional Industry Research
24.APAC Topical Pain Relief Market, By Distribution Channel Market 2019-2024 ($M)
24.1 Pharmacy Drug Store Market 2019-2024 ($M) - Regional Industry Research
24.2 E-Commerce Market 2019-2024 ($M) - Regional Industry Research
24.3 Grocery Store Market 2019-2024 ($M) - Regional Industry Research
25.MENA Topical Pain Relief Market, By Therapeutic Class Market 2019-2024 ($M)
25.1 Non-Opioids Market 2019-2024 ($M) - Regional Industry Research
25.1.1 Nonsteroidal Anti-Inflammatory Drug Market 2019-2024 ($M)
25.1.2 Methyl Salicylate Market 2019-2024 ($M)
25.1.3 Capsaicin Market 2019-2024 ($M)
25.1.4 Lidocaine Market 2019-2024 ($M)
25.2 Opioids Market 2019-2024 ($M) - Regional Industry Research
25.2.1 Buprenorphine Market 2019-2024 ($M)
25.2.2 Fentanyl Market 2019-2024 ($M)
26.MENA Topical Pain Relief Market, By Formulation Market 2019-2024 ($M)
26.1 Cream Market 2019-2024 ($M) - Regional Industry Research
26.2 Gel Market 2019-2024 ($M) - Regional Industry Research
26.3 Spray Market 2019-2024 ($M) - Regional Industry Research
26.4 Patch Market 2019-2024 ($M) - Regional Industry Research
27.MENA Topical Pain Relief Market, By Type Market 2019-2024 ($M)
27.1 Prescription Pain Relief Market 2019-2024 ($M) - Regional Industry Research
27.2 Over-The-Counter Pain Relief Market 2019-2024 ($M) - Regional Industry Research
28.MENA Topical Pain Relief Market, By Distribution Channel Market 2019-2024 ($M)
28.1 Pharmacy Drug Store Market 2019-2024 ($M) - Regional Industry Research
28.2 E-Commerce Market 2019-2024 ($M) - Regional Industry Research
28.3 Grocery Store Market 2019-2024 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Topical Pain Relief Market Revenue, 2019-2024 ($M)
2.Canada Topical Pain Relief Market Revenue, 2019-2024 ($M)
3.Mexico Topical Pain Relief Market Revenue, 2019-2024 ($M)
4.Brazil Topical Pain Relief Market Revenue, 2019-2024 ($M)
5.Argentina Topical Pain Relief Market Revenue, 2019-2024 ($M)
6.Peru Topical Pain Relief Market Revenue, 2019-2024 ($M)
7.Colombia Topical Pain Relief Market Revenue, 2019-2024 ($M)
8.Chile Topical Pain Relief Market Revenue, 2019-2024 ($M)
9.Rest of South America Topical Pain Relief Market Revenue, 2019-2024 ($M)
10.UK Topical Pain Relief Market Revenue, 2019-2024 ($M)
11.Germany Topical Pain Relief Market Revenue, 2019-2024 ($M)
12.France Topical Pain Relief Market Revenue, 2019-2024 ($M)
13.Italy Topical Pain Relief Market Revenue, 2019-2024 ($M)
14.Spain Topical Pain Relief Market Revenue, 2019-2024 ($M)
15.Rest of Europe Topical Pain Relief Market Revenue, 2019-2024 ($M)
16.China Topical Pain Relief Market Revenue, 2019-2024 ($M)
17.India Topical Pain Relief Market Revenue, 2019-2024 ($M)
18.Japan Topical Pain Relief Market Revenue, 2019-2024 ($M)
19.South Korea Topical Pain Relief Market Revenue, 2019-2024 ($M)
20.South Africa Topical Pain Relief Market Revenue, 2019-2024 ($M)
21.North America Topical Pain Relief By Application
22.South America Topical Pain Relief By Application
23.Europe Topical Pain Relief By Application
24.APAC Topical Pain Relief By Application
25.MENA Topical Pain Relief By Application
26.Advacare Pharma, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Glaxosmithkline Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Johnson Johnson, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Nestl S A, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Novartis Ag, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Pfizer Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Reckitt Benckiser Group Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Sanofi, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Sun Pharmaceutical Industry Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Topical Biomedics, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)